Featured Research

from universities, journals, and other organizations

New surgical hypertension treatment not as good as standard drug treatment

Date:
March 7, 2014
Source:
Oslo University Hospital
Summary:
A simple surgical procedure on the kidneys touted as a revolutionary treatment for high blood pressure turns out to be not so revolutionary after all. In a first its kind, a Norwegian clinical trial shows that established, standard drug treatment works better than the new surgical procedure. 

A simple surgical procedure on the kidneys touted as a revolutionary treatment for high blood pressure turns out to be not so revolutionary after all. In a first its kind, a Norwegian clinical trial shows that established, standard drug treatment works better than the new surgical procedure.

Some patients with high blood pressure are resistant to commonly used hypertension medication. New hope was raised for these patients a few years ago with the introduction of a simple surgical procedure called renal sympathetic denervation (RDN).

As recently as 2012, the method was referred to as a possible revolution in hypertension treatment. Tens of thousands of patients have already undergone the procedure in some European countries.

But Chief Physician Aud Hψieggen of Oslo University Hospital thinks the scientific basis for the RDN-method is weak. In a study published this week in the prestigious medical journal Hypertension, Aud Hψieggen and her researcher colleagues show that the new surgical procedure in fact is less effective than established drug treatment methods.


Story Source:

The above story is based on materials provided by Oslo University Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. F. E. M. Fadl Elmula, P. Hoffmann, A. C. Larstorp, E. Fossum, M. Brekke, S. E. Kjeldsen, E. Gjonnaess, U. Hjornholm, V. N. Kjaer, M. Rostrup, I. Os, A. Stenehjem, A. Hoieggen. Adjusted Drug Treatment Is Superior to Renal Sympathetic Denervation in Patients With True Treatment-Resistant Hypertension. Hypertension, 2014; DOI: 10.1161/%u200BHYPERTENSIONAHA.114.03246

Cite This Page:

Oslo University Hospital. "New surgical hypertension treatment not as good as standard drug treatment." ScienceDaily. ScienceDaily, 7 March 2014. <www.sciencedaily.com/releases/2014/03/140307084011.htm>.
Oslo University Hospital. (2014, March 7). New surgical hypertension treatment not as good as standard drug treatment. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2014/03/140307084011.htm
Oslo University Hospital. "New surgical hypertension treatment not as good as standard drug treatment." ScienceDaily. www.sciencedaily.com/releases/2014/03/140307084011.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) — You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) — The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) — As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) — When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins